Public Dashboard: Morningstar 4 Bargains (9/11/2020)
These undervalued wide-moat stocks earn low uncertainty ratings. -- Susan Dziubinski
| 10/31/2025 | ||||||||||||
| Company | Symbol | Shares | Price | Value | % of Total | Growth | Proj P/E | Proj Yield | Fin Str | EPS Stab | Qlty | PAR | 
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Averages | $555.08 | 3.6% | 14.8 | 2.6% | 39% | 57 | 57.7 | 8.1% | ||||
| Coca-Cola | KO | 1.96 | $68.98 | $135.10 | 24.3% | 4.6% | 21.7 | 3.0% | 61% | 97 | 89 | 8.2% | 
| Novartis | NVS | 1.11 | $122.61 | $136.42 | 24.6% | 5.6% | 19.0 | 3.2% | 64% | 70 | 84 | 9.8% | 
| Pfizer | PFE | 2.77 | $24.29 | $67.34 | 12.1% | 2.7% | 9.6 | 4.6% | 21% | 39 | 43 | 11.3% | 
| Roche Holdings* | RHHBY | 2.21 | $40.61 | $89.77 | 16.2% | 4.7% | 22.5 | 3.5% | 36% | 72 | 63 | 14.7% | 
| Vanguard Total Stock Market | VTSMX | 1.22 | $104.05 | $126.46 | 22.8% | 0.0% | 0.0 | 0.0% | 0% | 0 | 0 | -0.1% |